Clinical trials: CNI-intolerent
CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent
Blinatumomab for CNI-Resistant/Intolerant SRNS in Children
This exploratory clinical trial aims to evaluate the efficacy and safety of Blinatumomab in treating children with calcineurin inhibitor (CNI)-resistant or multidrug-resistant steroid-resistant nephrotic syndrome (SRNS).
- Conditions
- CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent, Steriod Resistant Nephrotic Syndrome, Multidrug Resistant Nephrotic Syndrome
- Trial name
- NCT06607991
- Testing
- Blinatumomab Treatment
- Where
- China
- Volunteers
- 6 people
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine